vs
Side-by-side financial comparison of Investar Holding Corp (ISTR) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
Investar Holding Corp is the larger business by last-quarter revenue ($23.5M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 0.9%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 4.9%).
Investar Holding Corp is a U.S.-headquartered bank holding company that primarily operates across the Gulf Coast region. It delivers a full range of commercial and retail banking services, including deposit products, consumer and business loans, mortgage services, and wealth management solutions for individual clients, small and medium-sized enterprises, and commercial entities.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
ISTR vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.5M | $13.2M |
| Net Profit | — | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 30.9% | -24.8% |
| Net Margin | — | -73.9% |
| Revenue YoY | 0.9% | 59.8% |
| Net Profit YoY | — | 3.5% |
| EPS (diluted) | $0.50 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.5M | $13.2M | ||
| Q3 25 | $24.1M | $11.6M | ||
| Q2 25 | $22.3M | $11.2M | ||
| Q1 25 | $24.0M | $9.2M | ||
| Q4 24 | $23.3M | $8.3M | ||
| Q3 24 | $22.3M | $7.3M | ||
| Q2 24 | $20.4M | $7.4M | ||
| Q1 24 | $21.4M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $6.2M | $-10.8M | ||
| Q2 25 | $4.5M | $-8.3M | ||
| Q1 25 | $6.3M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $5.4M | $-2.4M | ||
| Q2 24 | $4.1M | $-4.3M | ||
| Q1 24 | $4.7M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 30.9% | -24.8% | ||
| Q3 25 | 31.0% | -77.9% | ||
| Q2 25 | 24.4% | -65.4% | ||
| Q1 25 | 32.2% | -79.9% | ||
| Q4 24 | 31.1% | -91.8% | ||
| Q3 24 | 27.6% | -118.9% | ||
| Q2 24 | 24.0% | -111.0% | ||
| Q1 24 | 28.5% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | 25.6% | -93.5% | ||
| Q2 25 | 20.2% | -73.9% | ||
| Q1 25 | 26.3% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 24.1% | -32.6% | ||
| Q2 24 | 19.9% | -58.8% | ||
| Q1 24 | 22.0% | -204.5% |
| Q4 25 | $0.50 | $-0.22 | ||
| Q3 25 | $0.54 | $-0.96 | ||
| Q2 25 | $0.46 | $-0.27 | ||
| Q1 25 | $0.63 | $-0.39 | ||
| Q4 24 | $0.61 | $-0.38 | ||
| Q3 24 | $0.54 | $-0.12 | ||
| Q2 24 | $0.41 | $-0.21 | ||
| Q1 24 | $0.48 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | $9.8M | — |
| Stockholders' EquityBook value | $301.1M | $-33.9M |
| Total Assets | $2.8B | $35.3M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $9.8M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $301.1M | $-33.9M | ||
| Q3 25 | $295.3M | $-26.7M | ||
| Q2 25 | $255.9M | $-19.4M | ||
| Q1 25 | $251.7M | $-34.4M | ||
| Q4 24 | $241.3M | $-25.9M | ||
| Q3 24 | $245.5M | $-20.4M | ||
| Q2 24 | $230.2M | $-25.3M | ||
| Q1 24 | $227.0M | $-36.0M |
| Q4 25 | $2.8B | $35.3M | ||
| Q3 25 | $2.8B | $36.5M | ||
| Q2 25 | $2.7B | $41.3M | ||
| Q1 25 | $2.7B | $28.6M | ||
| Q4 24 | $2.7B | $24.0M | ||
| Q3 24 | $2.8B | $27.5M | ||
| Q2 24 | $2.8B | $32.4M | ||
| Q1 24 | $2.8B | $17.9M |
| Q4 25 | 0.03× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-2.5M | ||
| Q3 25 | $6.9M | $-3.7M | ||
| Q2 25 | $3.2M | $-7.3M | ||
| Q1 25 | $4.5M | $-4.5M | ||
| Q4 24 | $15.9M | $-5.7M | ||
| Q3 24 | $5.6M | $-10.8M | ||
| Q2 24 | $2.8M | $-13.4M | ||
| Q1 24 | $7.8M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.12× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
